Does addition of intravitreal bevacizumab confer additional benefit in management of proliferative diabetic retinopathy?


Article PDF :

Veiw Full Text PDF

Article type :

Original Article

Author :

Natasha Radhakrishnan*, Gopal S Pillai, Pooja Kandula, Mira Nair

Volume :

10

Issue :

1

Abstract :

Introduction: To evaluate visual outcome and complications of PDR after treatment with Intravitreal Bevacizumab followed by Pan Retinal Photocoagulation Materials and Methods: A hospital based retrospective study was done in the Department of Ophthalmology, to evaluate visual outcome and complications of PDR after treatment with intravitreal Bevacizumab followed by Pan Retinal Photocoagulation. Visual Acuity, Dilated fundus examination, OCT macula were done on subsequent follow ups Results: 135 eyes of 133 patients were included in the study.The mean pre procedure visual acuity is 0.639±0.5327 which improved to 0.451±0.4089 post procedure. P value is Conclusion: From our study it appears that addition of intravitreal anti VEGF to Pan Retinal Photocoagulation for PDR confers the additional benefit of less incidence of vitreous hemorrhage and less incidence of traction retinal detachment requiring surgery in the 1 one year of follow up. This amounts to more compliance by the patient for taking the treatment as well as better visual outcome

Keyword :

Diabetic retinopathy (PDR), Pan retinal photocoagulation (PRP), Vascular endothelial